New vaginal progesterone device tested for safety and ease of use
Symptom relief
Recruiting now
This early-stage trial tests a new vaginal product (Callavid) that delivers 400mg of progesterone to women with luteal phase insufficiency, a condition that can affect fertility. The study compares it to an existing pessary to see if it is safe, well-tolerated, and easy to use. 2…
Phase: PHASE1 • Sponsor: Calla Lily Clinical Care Ltd • Aim: Symptom relief
Last updated Jun 27, 2026 12:07 UTC